IPO Listed
Aktis Oncology IPO
US$318m raised
Lodged 8 Jan 2026 · NASDAQ: AKTS · US$18.00 cash per share
Advisers
Aktis Oncology
Issuer
Lead managers
- Legal adviser
- Issuer
- Aktis Oncology
- Issuer based in
- United States
- Listed
- 14 Jan 2026
- Sector
- Biotech
- Tags
- Biotech, Radiopharmaceuticals, Oncology
In the league tables
Similar deals
- Perspective Therapeutics equity raising Feb 2026 · US$175m · Radiopharmaceuticals
- Obsidian Therapeutics placement Apr 2026 · US$350m · Biotech
- Eikon Therapeutics IPO Feb 2026 · US$381m · Oncology
- Avenzo Therapeutics placement Jun 2026 · US$215m · Biotech
- Sensei Biotherapeutics placement Feb 2026 · US$200m · Biotech
Sources
- 9 Jan 2026 Final IPO prospectus (424B4), Aktis Oncology, Inc. sec.gov
- 9 Jan 2026 Aktis Oncology $318 million IPO davispolk.com
- 14 Jan 2026 Goodwin Advises Aktis Oncology in Closing of $365.4 Million Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares goodwinlaw.com



